Cargando…
Asymptomatic CNS demyelination related to TNF-α inhibitor therapy
Autores principales: | Ali, Farwa, Laughlin, Ruple S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087251/ https://www.ncbi.nlm.nih.gov/pubmed/27844038 http://dx.doi.org/10.1212/NXI.0000000000000298 |
Ejemplares similares
-
CNS-disseminated Angiostrongylus cantonensis mimicking atypical demyelinating disease
por: Long, Daniel, et al.
Publicado: (2019) -
CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017) -
Autopsy-proven demyelination associated with infliximab treatment
por: Bradshaw, Michael J., et al.
Publicado: (2016) -
Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy
por: Rinaldi, Francesca, et al.
Publicado: (2017) -
Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients
por: van der Zwan, Marieke, et al.
Publicado: (2020)